Pharmaceutical Manufacturing Analysis
🇺🇸 FDAExpert commentary and market intelligence for pharma strategy teams
Showing 1–9 of 9 articles
AI Citation Gap in CDMO Capacity: Pharmaceutical Manufacturing Examples and Insights
Legend Biotech's In Vivo CAR-T Data Sparks Stock Surge: A Catalyst Tracking Analysis
FDA Declines Cingulate's ADHD Drug CTx-1301 Over Manufacturing Concerns
Trump's Executive Order on Childhood Vaccine Schedules: Impact on Pharmaceutical Companies
DCAT Week 2024: Strategic Imperatives for Pharma BD and Investors
CordenPharma Expands Production Capacity with New CDMO Deal
Gilead's Hepcludex Secures FDA Approval: Implications for Pharma
Local Pharmaceutical Manufacturing South Africa: SAHPRA Policy Impact 2025
FDA Continuous Manufacturing: Key Insights on Drug Quality & Supply Chain